Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Dominik Rüttinger"'
Autor:
Michael A. Cannarile, Martin Weisser, Wolfgang Jacob, Anna-Maria Jegg, Carola H. Ries, Dominik Rüttinger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-13 (2017)
Abstract The tumor-permissive and immunosuppressive characteristics of tumor-associated macrophages (TAM) have fueled interest in therapeutically targeting these cells. In this context, the colony-stimulating factor 1 (CSF1)/colony-stimulating factor
Externí odkaz:
https://doaj.org/article/d178a458f1254b0b92d2840ec5a6df0e
Autor:
Ines Herrmann, Patrick A Baeuerle, Matthias Friedrich, Alexander Murr, Susanne Filusch, Dominik Rüttinger, Mariam W Majdoub, Sherven Sharma, Peter Kufer, Tobias Raum, Markus Münz
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13474 (2010)
With their resistance to genotoxic and anti-proliferative drugs and potential to grow tumors and metastases from very few cells, cancer stem or tumor-initiating cells (TICs) are a severe limitation for the treatment of cancer by conventional therapie
Externí odkaz:
https://doaj.org/article/13910e099a4c4b798c962a70c774ba98
Autor:
Carola H. Ries, Dominik Rüttinger, Hadassah Sade, Michael A. Cannarile, Solange Romagnoli, Chia-Huey Ooi, Leon P. Pradel
Correlation of certain epidemiological factors to a large donor cohort treated with RG7155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e5db1881dbf3c1f41a2705200290d63
https://doi.org/10.1158/1535-7163.22507959.v1
https://doi.org/10.1158/1535-7163.22507959.v1
Autor:
Carola H. Ries, Dominik Rüttinger, Hadassah Sade, Michael A. Cannarile, Solange Romagnoli, Chia-Huey Ooi, Leon P. Pradel
Additional details on primary human and cynomolgus material handling, RNA and DNA based assay design as well as SPR experimentation setup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ebdc489a50c0cf92175ab8d938aebff
https://doi.org/10.1158/1535-7163.22507944
https://doi.org/10.1158/1535-7163.22507944
Autor:
Carola H. Ries, Dominik Rüttinger, Hadassah Sade, Michael A. Cannarile, Solange Romagnoli, Chia-Huey Ooi, Leon P. Pradel
Information on primer sequences and conditions used for subsequent RT-PCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d337dcbd18f41ed693420370a57778
https://doi.org/10.1158/1535-7163.22507941
https://doi.org/10.1158/1535-7163.22507941
Autor:
Céline Adessi, Dominik Rüttinger
Publikováno v:
Immuno Oncology Insights. 3:305-310
Autor:
Jean J.L. Tessier, Christian Klein, Jean Gudas, Ian A. Wilson, Dominik Rüttinger, Pablo Umana, Marina Bacac, Peter Brünker, Claudia Ferrara, Christina Claus, Johannes Sam, Valeria G. Nicolini, Marine Richard, Preethi L.B. Mohan, Maria Amann, Mudita Pincha, Tapan K. Nayak, Green Zhang, Chenyu Lee, Daulet Satpayev, Filippo Marchioni, Jason M. Romero, Michael Torgov, Fang Jia, Charles Zamilpa, Ziyue Karen Jiang, Alessandro Mascioni, Tove Olafsen, Christoph M. Griessinger
Figure S6 shows the correlation of CD8-IHC and tumoruptake as determined by gamma-counting or PET.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6a13fe28eabcec76522fa717e14224
https://doi.org/10.1158/0008-5472.22425051.v1
https://doi.org/10.1158/0008-5472.22425051.v1
Autor:
Jean J.L. Tessier, Christian Klein, Jean Gudas, Ian A. Wilson, Dominik Rüttinger, Pablo Umana, Marina Bacac, Peter Brünker, Claudia Ferrara, Christina Claus, Johannes Sam, Valeria G. Nicolini, Marine Richard, Preethi L.B. Mohan, Maria Amann, Mudita Pincha, Tapan K. Nayak, Green Zhang, Chenyu Lee, Daulet Satpayev, Filippo Marchioni, Jason M. Romero, Michael Torgov, Fang Jia, Charles Zamilpa, Ziyue Karen Jiang, Alessandro Mascioni, Tove Olafsen, Christoph M. Griessinger
CD8-expressing T cells are the main effector cells in cancer immunotherapy. Treatment-induced changes in intratumoral CD8+ T cells may represent a biomarker to identify patients responding to cancer immunotherapy. Here, we have used a 89Zr-radiolabel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f178a6cff9e64f039bd22cb7364792b
https://doi.org/10.1158/0008-5472.c.6511935.v1
https://doi.org/10.1158/0008-5472.c.6511935.v1
Autor:
Jean J.L. Tessier, Christian Klein, Jean Gudas, Ian A. Wilson, Dominik Rüttinger, Pablo Umana, Marina Bacac, Peter Brünker, Claudia Ferrara, Christina Claus, Johannes Sam, Valeria G. Nicolini, Marine Richard, Preethi L.B. Mohan, Maria Amann, Mudita Pincha, Tapan K. Nayak, Green Zhang, Chenyu Lee, Daulet Satpayev, Filippo Marchioni, Jason M. Romero, Michael Torgov, Fang Jia, Charles Zamilpa, Ziyue Karen Jiang, Alessandro Mascioni, Tove Olafsen, Christoph M. Griessinger
Supplementary Material and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::125a069e0ac29cf2a409ad1674f98503
https://doi.org/10.1158/0008-5472.22425048
https://doi.org/10.1158/0008-5472.22425048
Autor:
Piergiorgio Pettazzoni, James R. Bischoff, Bruno Martoglio, Gabriel Schnetzler, Mitchell P. Levesque, Reinhard Dummer, David S. Hewings, Alessandro Brigo, Marina Bacac, Alison Ribeiro, Dominik Rüttinger, Daniela Krummenacher, Daniel Hunziker, Nicolas Frances, Frank Herting, Jan Eckmann, Jasmin Emmenegger, Cornelia Handl, Martin Kornacker, Jeannine Petrig-Schaffland, Thomas Friess, Caroline Rynn, Jürgen Wichmann
Purpose:Disease progression in BRAF V600E/K positive melanomas to approved BRAF/MEK inhibitor therapies is associated with the development of resistance mediated by RAF dimer inducing mechanisms. Moreover, progressing disease after BRAFi/MEKi frequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2843c44991336c397978b9069d4f8bb4
https://doi.org/10.1158/1078-0432.c.6531080.v1
https://doi.org/10.1158/1078-0432.c.6531080.v1